Journal of Korean Medical Science · 2014 · 17 citations · 21 references
MedicineOncologyPharmacologyApoptosisChemotherapyMolecular OncologyApoptosis In CancerApoptosis PharmacologyApoptosis ResistanceBcl-2 Family ProteinsCytotoxic ChemotherapyAnti-apoptotic ProteinsAnti-apoptotic RegulatorsApoptosis InductionApoptosis Signaling In CancerBcl-xl FunctionMcl-1 FunctionProteasome Inhibitor TherapyProteasome Inhibitors
Mcl-1 and Bcl-xL, key anti-apoptotic proteins of the Bcl-2 family, have attracted attention as important molecules in the cell survival and drug resistance. In this study, we investigated whether inhibition of Bcl-xL influences cell growth and apoptosis against simultaneous treatment of resveratrol and clofarabine in the human malignant mesothelioma H-2452 cells. Resveratrol and clofarabine decreased Mcl-1 protein levels but had little effect on Bcl-xL levels. In the presence of two compounds, any detectable change in the Mcl-1 mRNA levels was not observed in RT-PCR analysis, whereas pretreatment with the proteasome inhibitor MG132 led to its accumulation to levels far above basal levels. The knockdown of Bcl-xL inhibited cell proliferation with cell accumulation at G2/M phase and the appearance of sub-G0/G1 peak in DNA flow cytometric assay. The suppression of cell growth was accompanied by an increase in the caspase-3/7 activity with the resultant cleavages of procaspase-3 and its substrate poly (ADP-ribose) polymerase, and increased percentage of apoptotic propensities in annexin V binding assay. Collectively, our data represent that the efficacy of resveratrol and clofarabine for apoptosis induction was substantially enhanced by Bcl-xL-lowering strategy in which the simultaneous targeting of Mcl-1 and Bcl-xL could be a more effective strategy for treating malignant mesothelioma.
21
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival
Soraya Wuillème‐Toumi, Nelly Robillard, P Gomez et al. · Leukemia · 2005 · 338 citations
Medicine, Cell Biology, Oncology +13
Bcl2 family proteins in carcinogenesis and the treatment of cancer
Anna Frenzel, Francesca Grespi, Waldemar Chmelewskij et al. · APOPTOSIS · 2009 · 327 citations
Mathieu Derouet, Luke W. Thomas, Andrew Cross et al. · Journal of Biological Chemistry · 2004 · 224 citations · Full text